In the Spring of 2003, Kalorama published its first report on Outsourcing in Drug Discovery. Since then, so much has changed, the use of the term “2nd Edition” hardly seems appropriate. This new study involved completely re-examining the market from the ground up. This new report is designed to make readers aware of the enormous […]

This completely updated 2nd edition to Kalorama’s popular 2003 study focuses on the market applications of current and advanced drug delivery technology to the development of new and modified pharmaceutical products in the United States. Taking a strategic view of the various therapeutic areas on which drug delivery is anticipated to have its greatest impact, […]

Although, the next 15-20 years will shift a majority of the population into the elderly population group, children will continue to remain the bulk of the dependent population worldwide with 9 in every 10 people falling into a pediatric age range in the less developed regions of Africa, Asia and Latin America. Therefore, the treatment […]

Some of the biggest-selling biological drugs developed during the first phase of the biotechnology revolution in the 1980s, including human growth hormone (hGH) and insulin, are set to lose patent protection in the United States in 2005 and soon after. This opens up a market currently worth over $30 billion (and growing at over 10% […]

There has not been a year in the last decade in which the IVD market in China has failed to grow. With a gross domestic product of over $1.4 trillion, China surpassed Italy last year to become the world’s sixth largest economy, according to the International Monetary Fund. This country of 1.3 billion people is […]

Respiratory diseases are among the most common ailments across the world. Asthma and chronic obstructive pulmonary disease (COPD) are the major causes of mortality rates among children and elderly. Currently, about 300 million people suffer from asthma—the number only expected to rise over next few years—and about 14.2 million people suffer from COPD. Given these […]

Cancer, with its high prevalence and mortality rate, continues to rank among the world’s deadliest and most costly diseases. According to the WHO, in 2003, about 25 million people live with cancer and nearly 11 million new cases are diagnosed each year. With advances in protein and cell chemistry, genetics and molecular biology researchers are […]

Information technology (IT) has the potential to improve the quality, safety and efficiency of clinical care. IT is not new to the hospital setting. Computers and software have been used for many years to improve the paper-based administrative functions of hospital support staff, such as scheduling and billing. But the use of IT in the […]

In the industrial world, over 240 million people lack one or more teeth. It is estimated that 40% of the western population is missing one tooth or more. In the United States, approximately 10% is the population is totally edentulous, and every year about two million Americans loose a tooth due to sporting accidents. Although […]

This report considers the markets for therapeutic cardiovascular devices, such as prosthetic valves, pacemakers, stents, support devices, ICDs, VADs, and TAHs, in the United States as broken down into four major segments: cardiomyopathy/congestive heart failure arrhythmias arteriosclerosis (coronary artery disease), and valvular heart disease While there are other cardiovascular conditions that remain significant in the […]